Drug may cut blood transfusions in Kids' hip surgery

NCT ID NCT04811313

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving tranexamic acid (TXA) during hip reconstruction in children reduces blood loss and the need for blood transfusions. About 400 children will be randomly assigned to receive TXA, a nerve block, or standard care. The goal is to make surgery safer and speed up recovery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tranexamic acid
What this could lead to
If it works, this could mean fewer blood transfusions and safer recovery for children having hip surgery.
What could go wrong
This is a single-center trial, and results may not apply to all hospitals. There is also a small risk of side effects like seizures or blood clots from the drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAOPERATIVE BLOOD LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assiut University

    RECRUITING

    Asyut, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.